Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0901 | -8.27% | 0.9999 | 1.12 | 0.9799 | 1.12 | 1.09 | 15:21:32 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.99 | 0.9999 | 0.0098 | 0.98% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,115 | 605,294 | $ 1.03 | $ 624,997 | 1,262,032 | 0.74 - 16.49 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:21:32 | 6,103 | $ 0.9999 | USD |
Aclaris Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 40.54M | 41.37M | $ -132.74M | -4.04 | - | 39.59M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aclaris Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.8 | 1.1232 | 0.77 | 0.9534 | 1M | 0.1999 | 24.99% |
| 1 Month | 1.75 | 1.8219 | 0.74 | 1.0010 | 2M | -0.7501 | -42.86% |
| 3 Months | 4.8 | 5.5 | 0.74 | 1.8156 | 1M | -3.8001 | -79.17% |
| 6 Months | 6.82 | 7.51 | 0.74 | 3.4654 | 775k | -5.8201 | -85.34% |
| 1 Year | 15.5 | 16.49 | 0.74 | 5.7811 | 617k | -14.5001 | -93.55% |
| 3 Years | 20.84 | 33.25 | 0.74 | 14.2574 | 380k | -19.8401 | -95.20% |
| 5 Years | 11.94 | 33.88 | 0.74 | 14.4397 | 307k | -10.9401 | -91.63% |
Aclaris Therapeutics Description
| Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively. |
